A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026). Read more about A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026).
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer. Read more about Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases. Read more about The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases.
Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability. Read more about Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)? Read more about Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?
Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Read more about Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.
Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery. Read more about Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery.
Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Read more about Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.
